DOCS Analyst Ratings

Consensus: Mixed from 0 analysts.

Price Targets

Average Target
$43.36
High
$63.00
Low
$25.00

Recent Upgrades & Downgrades

DateFirmActionFromTo
Apr 13, 2026KeybancmaintainOverweightOverweight
Apr 9, 2026Goldman SachsmaintainNeutralNeutral
Apr 8, 2026Evercore ISI GroupdowngradeOutperformIn Line
Mar 9, 2026RBC CapitalmaintainOutperformOutperform
Feb 20, 2026Piper SandlermaintainOverweightOverweight